Egyptian International Pharmaceuticals, known as EIPICO, is one of Egypt's largest drugmakers. It turns basic chemistry into medicines that reach patients in 67 countries, and it has just posted the strongest year in its recent history. Full nameEgyptian International Pharmaceutical Industries Co. (EIPICO) Tickers / exchangePHAR on the Egyptian Exchange (EGX) Headquarters10th of Ramadan City, Sharqia Governorate, Egypt SectorPharmaceuticals Founded1990 Market valueNot published in available sources Yearly salesEGP 9.44 billion (US$180.4 million) — FY2025 Net profitEGP 1.458 billion (US$27.9 million) — FY2025 Net margin15.4% (our calculation) Return on equityNot published …
Egyptian International Pharmaceuticals (EIPICO)
·
September 5, 2026
·
3 min read
Company Intelligence — Institutional Access
This dossier is part of our Company Intelligence database.
Full profiles, exchange dossiers and the regional intelligence briefs are available to institutional subscribers. Professional from US$490/year, Corporate US$1,450, Institutional US$3,900.
See institutional access →Already a subscriber? Log in.
Part of LatAm Company Intelligence
This company profile belongs to The Rio Times' research on every listed company and exchange in Latin America and the Caribbean. Browse the full intelligence hub →
Not ready to buy? Try Company Intelligence free for 14 days →
Editorial responsibility: Matthias Camenzind, Editor-in-Chief · Editorial standards · Report an error
Read More from The Rio Times
The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →